517 related articles for article (PubMed ID: 25605410)
21. Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance.
Kubaichuk K; Kietzmann T
Cells; 2019 Jun; 8(6):. PubMed ID: 31208103
[TBL] [Abstract][Full Text] [Related]
22. Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms.
Guo J; Zhao J; Fu W; Xu Q; Huang D
Front Immunol; 2022; 13():918314. PubMed ID: 35935969
[TBL] [Abstract][Full Text] [Related]
23. The equilibrium of tumor suppression: DUBs as active regulators of PTEN.
Christine A; Park MK; Song SJ; Song MS
Exp Mol Med; 2022 Nov; 54(11):1814-1821. PubMed ID: 36385557
[TBL] [Abstract][Full Text] [Related]
24. Structurally-defined deubiquitinase inhibitors provide opportunities to investigate disease mechanisms.
Wertz IE; Murray JM
Drug Discov Today Technol; 2019 Apr; 31():109-123. PubMed ID: 31200854
[TBL] [Abstract][Full Text] [Related]
25. Deubiquitinases as potential anti-cancer targets for gold(III) complexes.
Zhang JJ; Ng KM; Lok CN; Sun RW; Che CM
Chem Commun (Camb); 2013 Jun; 49(45):5153-5. PubMed ID: 23629480
[TBL] [Abstract][Full Text] [Related]
26. Structure and function of the highly homologous deubiquitinases ubiquitin specific peptidase 25 and 28: Insights into their pathophysiological and therapeutic roles.
Zhou L; Qin B; Yassine DM; Luo M; Liu X; Wang F; Wang Y
Biochem Pharmacol; 2023 Jul; 213():115624. PubMed ID: 37245535
[TBL] [Abstract][Full Text] [Related]
27. H2A-DUBbing the mammalian epigenome: expanding frontiers for histone H2A deubiquitinating enzymes in cell biology and physiology.
Belle JI; Nijnik A
Int J Biochem Cell Biol; 2014 May; 50():161-74. PubMed ID: 24647359
[TBL] [Abstract][Full Text] [Related]
28. Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10.
Zhang W; Sartori MA; Makhnevych T; Federowicz KE; Dong X; Liu L; Nim S; Dong A; Yang J; Li Y; Haddad D; Ernst A; Heerding D; Tong Y; Moffat J; Sidhu SS
J Mol Biol; 2017 Nov; 429(22):3546-3560. PubMed ID: 28587923
[TBL] [Abstract][Full Text] [Related]
29. Multiplexed, Proteome-Wide Protein Expression Profiling: Yeast Deubiquitylating Enzyme Knockout Strains.
Isasa M; Rose CM; Elsasser S; Navarrete-Perea J; Paulo JA; Finley DJ; Gygi SP
J Proteome Res; 2015 Dec; 14(12):5306-17. PubMed ID: 26503604
[TBL] [Abstract][Full Text] [Related]
30. The therapeutic potential of deubiquitinating enzyme inhibitors.
Colland F
Biochem Soc Trans; 2010 Feb; 38(Pt 1):137-43. PubMed ID: 20074048
[TBL] [Abstract][Full Text] [Related]
31. Harnessing the oxidation susceptibility of deubiquitinases for inhibition with small molecules.
Ohayon S; Refua M; Hendler A; Aharoni A; Brik A
Angew Chem Int Ed Engl; 2015 Jan; 54(2):599-603. PubMed ID: 25327786
[TBL] [Abstract][Full Text] [Related]
32. Editorial: Ubiquitin E3 Ligases as Molecular Targets or Tools for Advanced Cancer Therapy.
Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):100. PubMed ID: 26791134
[No Abstract] [Full Text] [Related]
33. Structural basis for specific inhibition of the deubiquitinase UCHL1.
Grethe C; Schmidt M; Kipka GM; O'Dea R; Gallant K; Janning P; Gersch M
Nat Commun; 2022 Oct; 13(1):5950. PubMed ID: 36216817
[TBL] [Abstract][Full Text] [Related]
34. Deubiquitylating enzymes and DNA damage response pathways.
Jacq X; Kemp M; Martin NM; Jackson SP
Cell Biochem Biophys; 2013 Sep; 67(1):25-43. PubMed ID: 23712866
[TBL] [Abstract][Full Text] [Related]
35. Deubiquitinases and cancer: A snapshot.
Singh N; Singh AB
Crit Rev Oncol Hematol; 2016 Jul; 103():22-6. PubMed ID: 27211605
[TBL] [Abstract][Full Text] [Related]
36. The role of aberrant proteolysis in lymphomagenesis.
Sahasrabuddhe AA; Elenitoba-Johnson KS
Curr Opin Hematol; 2015 Jul; 22(4):369-78. PubMed ID: 26049759
[TBL] [Abstract][Full Text] [Related]
37. Deubiquitinating enzymes as novel anticancer targets.
Nicholson B; Marblestone JG; Butt TR; Mattern MR
Future Oncol; 2007 Apr; 3(2):191-9. PubMed ID: 17381419
[TBL] [Abstract][Full Text] [Related]
38. Ubiquitin-specific proteases as therapeutic targets for the treatment of breast cancer.
Pal A; Donato NJ
Breast Cancer Res; 2014; 16(5):461. PubMed ID: 25606592
[TBL] [Abstract][Full Text] [Related]
39. DUBs, the regulation of cell identity and disease.
Heideker J; Wertz IE
Biochem J; 2015 Jan; 465(1):1-26. PubMed ID: 25631680
[TBL] [Abstract][Full Text] [Related]
40. E3 ubiquitin ligases in cancer and implications for therapies.
Wang D; Ma L; Wang B; Liu J; Wei W
Cancer Metastasis Rev; 2017 Dec; 36(4):683-702. PubMed ID: 29043469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
